Medicare Enrolled
Dr. Benjamin Dubin, M.D.
Optician · Gurnee, IL
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Dubin from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Dubin?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Dubin
Dr. Benjamin Dubin is an optician specialist in Gurnee, IL, with 19 years of NPI registration. Based on federal Medicare data, Dr. Dubin performed 1,774 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Dubin received a total of $19,363 from 47 pharmaceutical and/or device companies across 874 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Dubin is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years of NPI registration
▲ Top 35% volume in IL
$19,363 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗1,774
Medicare services
Top 35% in IL for optician
Not available
Unique patients (not deduplicated)
$69
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| UV therapy with tar or petroleum jelly A treatment using ultraviolet radiation combined with the application of tar or petroleum jelly to the skin. |
327 | $100 | $190 |
| Destruction of precancerous skin growths, 2-14 This procedure involves the removal or destruction of two to fourteen precancerous skin lesions. It is performed to eliminate abnormal skin cells that have the potential to develop into cancer. |
325 | $5 | $21 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
192 | $87 | $344 |
| Destruction of precancerous skin growth, 1 Removal of a single precancerous skin growth. This procedure destroys abnormal skin cells to prevent them from developing into cancer. |
179 | $46 | $206 |
| Steroid injection (triamcinolone) A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered. |
171 | $1 | $25 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
151 | $66 | $234 |
| Destruction of skin growths (warts/lesions), 1-14 This procedure involves the removal or destruction of one to fourteen skin growths. It is a minor surgical intervention performed on the skin surface. |
104 | $84 | $289 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
74 | $123 | $450 |
| Skin biopsy, tangential A procedure to remove a sample of the first identified skin growth for laboratory examination. |
73 | $75 | $267 |
| Topical aminolevulinic acid HCl 20% solution A topical medication applied to the skin for medical treatment. It is supplied as a single-unit dosage form containing 354 mg of the active ingredient. |
61 | $303 | $700 |
| Light therapy to destroy precancerous skin growth A qualified healthcare professional applies light to the skin to destroy precancerous growths. |
43 | $186 | $485 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
37 | $80 | $353 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
26 | $11 | $62 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
11 | $44 | $142 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$19,363
Total received (2018-2024)
Avg $2,766/year across 7 years
Top 5% in IL for optician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
47
Companies
874
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,572
2023
$2,055
2022
$2,134
2021
$2,632
2020
$1,633
2019
$4,335
2018
$4,002
Payments by company (2024)
ABBVIE INC.
$363
Lilly USA, LLC
$339
GENZYME CORPORATION
$334
UCB, Inc.
$286
Regeneron Healthcare Solutions, Inc.
$268
E.R. Squibb & Sons, L.L.C.
$242
SUN PHARMACEUTICAL INDUSTRIES INC.
$115
Novartis Pharmaceuticals Corporation
$87
MAYNE PHARMA COMMERCIAL LLC
$85
Arcutis Biotherapeutics, Inc.
$82
Sandoz Inc.
$77
Verrica Pharmaceuticals Inc.
$72
Incyte Corporation
$47
Dermavant Sciences, Inc.
$42
STRATA Skin Sciences, Inc.
$41
Amgen Inc.
$36
LEO Pharma Inc.
$27
PFIZER INC.
$15
Boehringer Ingelheim Pharmaceuticals, Inc.
$13
Top 3 companies account for 40.3% of 2024 payments
All-time payments by company (2018-2024) ›
AbbVie, Inc.
$1,982
GENZYME CORPORATION
$1,451
Lilly USA, LLC
$1,449
Regeneron Healthcare Solutions, Inc.
$1,423
AbbVie Inc.
$1,227
LEO Pharma Inc.
$1,035
Amgen Inc.
$959
Biofrontera Inc.
$905
ABBVIE INC.
$848
Sun Pharmaceutical Industries Inc.
$691
Celgene Corporation
$675
UCB, Inc.
$619
Janssen Biotech, Inc.
$610
E.R. Squibb & Sons, L.L.C.
$594
Merz North America, Inc.
$587
Novartis Pharmaceuticals Corporation
$563
Ortho Dermatologics, a division of Bausch Health US, LLC
$357
Galderma Laboratories, L.P.
$342
Mayne Pharma Inc.
$341
SUN PHARMACEUTICAL INDUSTRIES INC.
$292
PFIZER INC.
$261
EPI Health, LLC
$256
Janssen Scientific Affairs, LLC
$231
Incyte Corporation
$175
Genentech USA, Inc.
$165
Sandoz Inc.
$133
DERMIRA, INC.
$125
MAYNE PHARMA COMMERCIAL LLC
$120
NOVARTIS PHARMACEUTICALS CORPORATION
$92
Dermavant Sciences, Inc.
$91
Arcutis Biotherapeutics, Inc.
$82
SANOFI-AVENTIS U.S. LLC
$80
MAYNE PHARMA INC.
$77
Almirall LLC
$76
Verrica Pharmaceuticals Inc.
$72
Mylan Pharmaceuticals Inc.
$71
Boehringer Ingelheim Pharmaceuticals, Inc.
$66
Taro Pharmaceuticals USA, Inc.
$57
STRATA Skin Sciences, Inc.
$41
Mission Pharmacal Company
$26
Bayer HealthCare Pharmaceuticals Inc.
$25
Kyowa Kirin, Inc.
$21
Journey Medical Corporation
$16
Medimetriks Pharmaceuticals, Inc.
$16
Aclaris Therapeutics, Inc.
$14
Helsinn Therapeutics (U.S.), Inc.
$12
DUSA Pharmaceuticals, Inc.
$12
Top 3 companies account for 25.2% of all-time payments
Associated products mentioned in payments ›
0.25% · ABSORICA · ABSORICA (isotretinoin) · ABSORICA LD · ADBRY · AKLIEF · ALTRENO · AMELUZ · APEXICON E · ARAZLO · Absorica LD · Ameluz · Avar · BLU-U · BRYHALI · Bensal HP · Bimzelx · COSENTYX · CYLTEZO · Cimzia · Cordran · DORYX · DUOBRII · DUPIXENT · DUPIXENT DUPILUMAB INJECTION · ENSTILAR · EPIDUO FORTE · EUCRISA · Enbrel · Erivedge · FINACEA · Finacea · HALOG OINTMENT (Halcinonide Ointment · HUMIRA · HYRIMOZ · Humira · ILUMYA · ILUMYA (tildrakizumab-asmn) injection · Ilumya · JUBLIA · LEVULAN KERASTICK · LIBTAYO · LOCOID · Neo-Synalar · OLUMIANT · ONEXTON · OPZELURA · ORACEA · Olux · Olux-E · Otezla · Ovace · POTELIGEO · QBREXZA · REMICADE · RHOFADE · RINVOQ · SILIQ · SIMPONI · SKYRIZI · SOOLANTRA · SPEVIGO · Seysara · Sitavig · Skyrizi · Sotyktu · TALTZ · TOPICORT (desoximetasone) Topical Spray · TREMFYA · Tremfya · USP) 0.1% · VALCHLOR · VEREGEN · VTAMA · Winlevi · XELJANZ · XTRAC · Xolair · YCANTH · Zoryve
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Opticians in nearby ZIP areas
249
County median income
$108,917
Nearest hospital to ZIP centroid (approximate)
VISTA MEDICAL CENTER EAST
4.2 mi
4.2 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Dubin is a clinical cardiology specialist, with moderate Medicare volume, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Dubin experienced with uv therapy with tar or petroleum jelly?
Based on Medicare claims data, Dr. Dubin performed 327 uv therapy with tar or petroleum jelly services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Dubin receive payments from pharmaceutical companies?
Yes. Dr. Dubin received a total of $19,363 from 47 companies across 874 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Dubin's costs compare to other opticians in Gurnee?
Dr. Dubin's average Medicare payment per service is $69. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Dubin) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Opticians in Gurnee
Browse opticians in Gurnee ranked by procedure volume and transparency data.
Highest volume
Top Opticians in IL
Opticians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Opticians in IL
Which IL opticians receive the most from drug and device companies.
By company
AbbVie, Inc. Payments to Doctors
See all physicians who received payments from AbbVie, Inc.
By company
GENZYME CORPORATION Payments to Doctors
See all physicians who received payments from GENZYME CORPORATION.
By company
Lilly USA, LLC Payments to Doctors
See all physicians who received payments from Lilly USA, LLC.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology